Dr. Anca Mihaela Avram, MD

Dr. Avram practices at MetroHealth Main Campus Medical Center in Cleveland, Ohio, part of Cuyahoga County.

Dr. Avram's NPI, 1174616098, was assigned on October 2, 2006. Dr. Avram graduated from Carol Davila University of Medicine and Pharmacy in 1992. Dr. Avram's Ohio license number on file is 35.078284.

Dr. Avram's primary practice is MetroHealth Main Campus Medical Center, at 2500 Metrohealth Drive, Cleveland, OH 44109 in Cuyahoga County. The practice phone is (216) 778-7089.

Dr. Avram's primary practice is MetroHealth Main Campus Medical Center in Cleveland, Ohio, part of Cuyahoga County. The medical group on file is MetroHealth Professional Group. Dmand AI also links Dr. Avram to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Avram practices. Vendor and product names are available with a free account.

Nuclear medicine is Dr. Avram's primary specialty in the NPI Registry, under taxonomy code 207U00000X. Dr. Avram is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Dr. Avram's licenses on file in 3 states: Ohio, Texas and Michigan.

CMS data shows 237 Medicare services from Dr. Avram across 6 procedure codes in 2024, for 268 Medicare patients. Medicare paid $16,333 for them.

CMS counts 268 Medicare patients who saw Dr. Avram in 2024. The largest group is 65 to 74, with 145 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Avram's median patient age at 71, with 54% women.

In 2024, Dr. Avram wrote 18 Medicare Part D claims. 67% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $110 in total drug cost. In 2022, CMS named 15 claims across 1 drug.

Dr. Avram accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 24 papers to Dr. Avram, published from 2005 to 2019. 2017 was the busiest year, with 2. The most frequent topics are Thyroid Neoplasms, Iodine Radioisotopes and Fluorodeoxyglucose F18. Dr. Avram has published most often in J Clin Endocrinol Metab. Dr. Avram's most frequent co-authors are Bennett Steven Greenspan, MD, Milton David Gross, MD and Robert M. Tuttle, MD.

CMS Open Payments shows 31 general payments to Dr. Avram from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 77% of the total. Bristol-Myers Squibb Company paid the most, $7,625.

Dr. Avram graduated from Carol Davila University of Medicine and Pharmacy in 1992.

Dr. Avram is in network with 4 carriers, including Molina, United Healthcare and CMS Medicare. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.